Share on:
Shanghai Sanyou Medical received a $14.0MM investment from Chinese investment firm Yingke Private Equity. Sanyou plans to use the funds to invest in research and development, as well as accelerate its initial public offering process.
Founded in 2005, the orthopaedic device developer holds 21 patents and 48 utility models in China. Products include “Z” Minimally Invasive Spine Technology that purportedly reduces surgery time by 50% and surgical incision size by 30%. The company’s Tytus Labs offers R&D assistance from prototyping to mechanical and biomechanical analysis.
As a startup, the company raised Series A funds with investments from Qiming Venture Partners and TF Capital in 2014.
Sources: Shanghai Sanyou Medical
RELATED ARTICLES
Janco Medical to Focus on Packaging and Cleanroom Manufacturing
Apr 10 2024 , Julie A. Vetalice
Evonik Grows Capacity for Customized RESOMER Powder Biomaterials
Apr 10 2024 , Julie A. Vetalice
Exploring Why Automation Leads to Improved Medical Device Manufacturing
Apr 09 2024 , Lowell